Programmed death ligand 1 testing in non-small cell lung carcinoma cytology cell block and aspirate smear preparations.
Bryce NollWei-Lien WangYun GongJun ZhaoNeda KalhorVictor PrietoGregg StaerkelSinchita Roy-ChowdhuriPublished in: Cancer cytopathology (2018)
The results show that NSCLC cytology samples evaluated for PD-L1 have high concordance with paired core-needle biopsy samples and can be used for assessing PD-L1 expression. Cancer Cytopathol 2018;126:342-52. © 2018 American Cancer Society.